Stock Comparison

INSM vs VRTX

Insmed Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

INSM

Insmed Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$26.84B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

15.4

25.7

Price/Sales

23.6

9.9

Price/Book

35.4

6.1

EV/EBITDA

-5.7

23.2

Dividend Yield

—

Profitability

Net Margin

-144.44%

35.40%

Operating Margin

-137.74%

38.97%

Return on Equity

-87.20%

23.50%

Return on Assets

-22.20%

11.90%

Growth (YoY)

Revenue Growth

296.10%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

0.8

0.3

52-Week High

$211.41

$529.65

52-Week Low

$91.88

$376.62

Analyst Target

$197.82

$559.28

Compare INSM and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.